MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from ASPIRE

    A. Esquenazi, W. Feng, G. Wittenberg, P. Gallien, A. Baricich, K. Fanning, A. Zuzek, G. Francisco, D. Bandari (Elkins Park, PA, USA)

    Objective: To identify patient demographics and clinical characteristics that impact onabotulinumtoxinA treatment adherence from the Adult Spasticity International Registry (ASPIRE) study. Background: A better understanding…
  • 2019 International Congress

    Ecopipam, a selective D1 antagonist in development for the treatment of Tourette syndrome in children and adolescents: The Phase 2b D1AMOND Study

    J. Dubow, D. Kim, R. Bittman, S. Wanaski, J. Swalec, T. Cunniff (Northbrook, IL, USA)

    Objective: To describe the Phase 2b study design and optimized dosing strategy to evaluate the efficacy and safety of ecopipam in children and adolescent subjects…
  • 2019 International Congress

    Is there evidence of bradykinesia in patients with Essential Tremor?

    D. Colella, M. Bologna, G. Paparella, A. Cannavacciuolo, S. Pietracupa, A. Guerra, A. Berardelli (Rome, Italy)

    Objective: To evaluate possible abnormalities (bradykinesia) of repetitive finger movements, including the sequence effect, using kinematic techniques in patients with ET. Background: Essential tremor (ET)…
  • 2019 International Congress

    Different patterns of cortical and subcortical perfusion changes in essential tremor and tremor-dominant Parkinson’s disease using voxel-based analysis of 3D arterial spin-labeling imaging

    L. Jin, J. Wang, C. Wang (Shanghai, China)

    Objective: We aimed to evaluate cerebral blood flow (CBF) in patients with untreated ET, de novo tremor-dominant PD (PDT) and age- and gender- matched controls…
  • 2019 International Congress

    ADL impairment and quality of life in patients with essential tremor

    P. Reker, S. Schnitzler, T. Thies, A. Josten, J. Becker, J. Steffen, J. Wirths, H. Dafsari, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)

    Objective: To investigate the relationship of tremor severity, disease related quality of life (QoL) and impairment of activities of daily living (ADL) in patients with…
  • 2019 International Congress

    Substantia Nigra Hyperechogenicity in Parkinson’s Disease and Essential Tremor and its Association with Premotor Symptoms of Parkinson’s Disease

    M. Uribe Roca, A. Chertcoff, L. Bandeo, M. Saucedo, F. Pantiu, L. de Francesco, L. Leon Cejas, M. Pacha, G. Napoli, P. Bonardo, O. Martinez, M. Fernandez Pardal, R. Reisin (Buenos Aires, Argentina)

    Objective: To compare the frequency of Substantia Nigra hyperechogenicity (SN+) in patients with essential tremor (ET) and Parkinson’s disease (PD), to determine the frequency of…
  • 2019 International Congress

    Quercetin administration abrogates the Parkinson’s disease (PD)-like motor and non-motor symptoms and attenuates the behavioral, neurochemical and biochemical deficits induced by rotenone toxicity in rats

    S. Madiha, S. Haider (Karachi, Pakistan)

    Objective: The present study was carried out to investigate the preventive and therapeutic effects of quercetin (a flavonol) against rotenone-induced neurotoxicity. Background: Rotenone (pesticide) induced…
  • 2019 International Congress

    Ixcellence Network®, an International Innovative Educational Programme To Improve Cervical Dystonia And Spastic Paresis Management: Feedback survey from 839 attendees

    C. Colosimo, TM. Chung, LJ. Jacinto, K. Bhatia, A. Fulford-Smith, R. Bhidayasiri (Roma, Italy)

    Objective: To assess the Ixcellence Network® training programme educative quality and impact on physicians using botulinum neurotoxin-A (BoNT-A) in cervical dystonia (CD) and spastic paresis…
  • 2019 International Congress

    Influence of Cognitive Deficits and Tremor Severity of the Development of Depression in Nondemented Patients with Essential Tremor

    M. Petrova, O. Grigorova, M. Raycheva, L. Traykov (Sofia, Bulgaria)

    Objective: The aim of this study was to investigate the relationship between cognitive deficits and tremor severity with the development of depression in nondemented ET…
  • 2019 International Congress

    The prevalence of supine hypertension and nocturnal hypertension and the difference of blood pressure in each sleep position in Parkinson’s disease

    J. Sringean, R. Hamindra, R. Bhidayasiri (Bangkok, Thailand)

    Objective: This study aimed to determine the prevalence, associated factors of SH/NH and to identify relationships between blood pressure (BP) and sleep position in PD…
  • « Previous Page
  • 1
  • …
  • 214
  • 215
  • 216
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley